Self-Contained Lateral-Flow Microfluidic Bead-Based Assay for Rapid Quantification of Early-Stage Kidney Biomarkers
Analytical Chemistry · 14.07.2026 · 98 (27) · 20204-20217
DOI: 10.1021/acs.analchem.6c01144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 01.07.2026. Verfasst von Gloria Porro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Life Science Electronics, École Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland. Hauptthemen laut MEDLINE: Cystatin C, Lipocalin-2, Microfluidic Analytical Techniques, Polycystic Kidney Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur F??rderung der Wissenschaftlichen Forschung, Innosuisse - Schweizerische Agentur f??r Innovationsf??rderung.
Abstract (Originalsprache)
Kidney diseases, whether acute or chronic, remain among the most challenging conditions to diagnose due to their complex and often asymptomatic progression. Emerging biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C (CysC) correlate with early pathogenesis and offer complementary insights into disease etiology. However, quantification of their levels, which is essential for patient staging, is available only in centralized laboratories. We present the lateral-flow microfluidic bead-based assay (LMBA), the first rapid, self-contained system for NGAL and CysC analysis. LMBA integrates a microfluidic chip with paper-based components to run automated high-resolution immunoassays in 20 min. Its modular architecture, decoupling reagent storage and flow control from assay binding and readout, offers significant design flexibility. Validated against ELISA, LMBA exhibits comparable sensitivity with an extended dynamic range, requiring only 1 μL of the original blood or urine sample prior to dilution. We applied the LMBA to neonatal mouse models of polycystic kidney disease and measured biomarker elevations consistent with cyst progression. This scalable platform supports preclinical research and holds strong potential for decentralized kidney disease diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Life Science Electronics, École Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland.
- Laboratory of Developmental and Cancer Cell Biology, École Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland.
- Rea Diagnostics SA, Lausanne 1015, Switzerland.
ORCID-Profile: Gloria Porro, Pierre-Emmanuel Thiriet
Förderung
- Schweizerischer Nationalfonds zur F??rderung der Wissenschaftlichen Forschung
- Innosuisse - Schweizerische Agentur f??r Innovationsf??rderung
Zitieren
APA
Porro, G., Cristofori, M. S., Gagnieux, C., Pennati, E., Thiriet, P. E., Constam, D., & Guiducci, C. (2026). Self-Contained Lateral-Flow Microfluidic Bead-Based Assay for Rapid Quantification of Early-Stage Kidney Biomarkers. Analytical Chemistry, 98(27), 20204-20217. https://doi.org/10.1021/acs.analchem.6c01144
Vancouver
Porro G, Cristofori MS, Gagnieux C, Pennati E, Thiriet PE, Constam D, et al. Self-Contained Lateral-Flow Microfluidic Bead-Based Assay for Rapid Quantification of Early-Stage Kidney Biomarkers. Analytical Chemistry. 2026;98(27):20204-20217. doi:10.1021/acs.analchem.6c01144
BibTeX
@article{Porro2026,
author = {Porro, Gloria and Cristofori, Micaela Siria and Gagnieux, Céline and Pennati, Elia and Thiriet, Pierre-Emmanuel and Constam, Daniel and Guiducci, Carlotta},
title = {Self-Contained Lateral-Flow Microfluidic Bead-Based Assay for Rapid Quantification of Early-Stage Kidney Biomarkers},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {27},
pages = {20204--20217},
doi = {10.1021/acs.analchem.6c01144}
}
EUVIMED